Igen Biolab Group
  • Home
  • About us
  • Pipeline
  • Tecnology
  • Press
    • News
    • Press Releases
    • Events
    • Publications
  • Contact
  • English
    • Español
Select Page
Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment

Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment

by Igen BioLab Group | Aug 16, 2023 | Events, News

The human gut is a host for trillions of microorganisms, divided into more than 3,000 heterogeneous species that is called the gut microbiota. The gut microbiota composition can be altered by many different endogenous and exogenous factors, especially diet and...
Gut microbiome immaturity and childhood acute lymphoblastic leukaemia

Gut microbiome immaturity and childhood acute lymphoblastic leukaemia

by Igen BioLab Group | Aug 7, 2023 | Events, News

Acute lymphoblastic leukaemia (ALL) accounts for one-third of paediatric cancer cases in developed societies1. Although treatment of paediatric ALL is highly successful with cure rates of around 90%2, the longer-term complications of therapy and impact on quality of...
Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy—a cross-sectional study

Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy—a cross-sectional study

by Igen BioLab Group | Jun 13, 2023 | News

Periodontitis is one of the world’s most prevalent infectious conditions, affecting between 25 and 40% of the adult population. It is a consequence of the complex interactions between periodontal pathogens and their products, which trigger the host inflammatory...
Interplay Between Gut Microbiota and the Host Immune System: What Do We Know and What Is on the Horizon?

Interplay Between Gut Microbiota and the Host Immune System: What Do We Know and What Is on the Horizon?

by Igen BioLab Group | Jun 30, 2022 | News

Key Points Researchers have identified a connection between unfavorable gut bacteria and laboratory markers of inflammation in patients with non–small cell lung cancer, which in turn correlate with a poor response to immune checkpoint inhibitor therapy. Three phase 1...

Recent Posts

  • Elucidating colorectal cancer-associated bacteria through profiling of minimally perturbed tissue-associated microbiota
  • Intratumor microbiota: a novel tumor component
  • Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
  • Chasing the Mysteries of Microbiome Communication in Our Bodies
  • Advances in the Microbiome, Immunity and Cancer interplay
  • LEGAL NOTICE
  • PRIVACY AND DATA PROTECTION
  • Cookie policy
  • Facebook
  • X
  • Instagram
  • RSS
Design by loComunicas

This website uses its own and third-party cookies in order to analyze the traffic generated for statistical purposes.

You can accept all cookies by clicking "Accept", reject all of them by clicking "Deny" or configure them by clicking "Settings".

For more information on how this site uses cookies and related technologies, you can read our Policy on Cookies

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly necessary cookies

Strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

If you deactivate this cookie, we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Please activate the strictly necessary cookies first so that we can save your preferences!

Cookies policy

More information about our cookie policy